Thermal ablative therapies for secondary hepatic malignancies

Skye C. Mayo, Timothy M. Pawlik

Research output: Contribution to journalArticle

Abstract

Hepatic metastatic disease affects more than half of the patients with colorectal cancer and neuroendocrine cancer. Hepatic resection remains the gold standard for liver metastasis from colorectal and neuroendocrine primaries. Thermal ablative technologies, however, are increasingly being used either alone or in combination with resection to treat this group of patients. Radiofrequency ablation is the most common modality used in the United States, whereas microwave ablation has been more widely used in the East. In addition to being adjuncts to hepatic resection, ablation has gained an increased popularity in the management of patients who are not operative candidates or have unresectable colorectal or neuroendocrine hepatic metastasis. Although radiofrequency ablation seems to have a higher local recurrence than resection, ablation remains an important therapeutic option for many patients with hepatic metastasis.

Original languageEnglish (US)
Pages (from-to)111-117
Number of pages7
JournalCancer Journal
Volume16
Issue number2
DOIs
StatePublished - Mar 2010

Fingerprint

Hot Temperature
Liver
Neoplasms
Neoplasm Metastasis
Therapeutics
Microwaves
Colorectal Neoplasms
Technology
Recurrence

Keywords

  • Colorectal metastases
  • Hatic resection
  • Liver
  • Microwave ablation
  • Nuroendocrine metastases
  • Radiofrequency ablation
  • Surgery

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Thermal ablative therapies for secondary hepatic malignancies. / Mayo, Skye C.; Pawlik, Timothy M.

In: Cancer Journal, Vol. 16, No. 2, 03.2010, p. 111-117.

Research output: Contribution to journalArticle

Mayo, Skye C. ; Pawlik, Timothy M. / Thermal ablative therapies for secondary hepatic malignancies. In: Cancer Journal. 2010 ; Vol. 16, No. 2. pp. 111-117.
@article{9b1c9cbcb960456692985c715c05ff3e,
title = "Thermal ablative therapies for secondary hepatic malignancies",
abstract = "Hepatic metastatic disease affects more than half of the patients with colorectal cancer and neuroendocrine cancer. Hepatic resection remains the gold standard for liver metastasis from colorectal and neuroendocrine primaries. Thermal ablative technologies, however, are increasingly being used either alone or in combination with resection to treat this group of patients. Radiofrequency ablation is the most common modality used in the United States, whereas microwave ablation has been more widely used in the East. In addition to being adjuncts to hepatic resection, ablation has gained an increased popularity in the management of patients who are not operative candidates or have unresectable colorectal or neuroendocrine hepatic metastasis. Although radiofrequency ablation seems to have a higher local recurrence than resection, ablation remains an important therapeutic option for many patients with hepatic metastasis.",
keywords = "Colorectal metastases, Hatic resection, Liver, Microwave ablation, Nuroendocrine metastases, Radiofrequency ablation, Surgery",
author = "Mayo, {Skye C.} and Pawlik, {Timothy M.}",
year = "2010",
month = "3",
doi = "10.1097/PPO.0b013e3181d7ea07",
language = "English (US)",
volume = "16",
pages = "111--117",
journal = "Cancer journal (Sudbury, Mass.)",
issn = "0765-7846",
publisher = "Association Pour le Developpement de la Communication Cancerologique",
number = "2",

}

TY - JOUR

T1 - Thermal ablative therapies for secondary hepatic malignancies

AU - Mayo, Skye C.

AU - Pawlik, Timothy M.

PY - 2010/3

Y1 - 2010/3

N2 - Hepatic metastatic disease affects more than half of the patients with colorectal cancer and neuroendocrine cancer. Hepatic resection remains the gold standard for liver metastasis from colorectal and neuroendocrine primaries. Thermal ablative technologies, however, are increasingly being used either alone or in combination with resection to treat this group of patients. Radiofrequency ablation is the most common modality used in the United States, whereas microwave ablation has been more widely used in the East. In addition to being adjuncts to hepatic resection, ablation has gained an increased popularity in the management of patients who are not operative candidates or have unresectable colorectal or neuroendocrine hepatic metastasis. Although radiofrequency ablation seems to have a higher local recurrence than resection, ablation remains an important therapeutic option for many patients with hepatic metastasis.

AB - Hepatic metastatic disease affects more than half of the patients with colorectal cancer and neuroendocrine cancer. Hepatic resection remains the gold standard for liver metastasis from colorectal and neuroendocrine primaries. Thermal ablative technologies, however, are increasingly being used either alone or in combination with resection to treat this group of patients. Radiofrequency ablation is the most common modality used in the United States, whereas microwave ablation has been more widely used in the East. In addition to being adjuncts to hepatic resection, ablation has gained an increased popularity in the management of patients who are not operative candidates or have unresectable colorectal or neuroendocrine hepatic metastasis. Although radiofrequency ablation seems to have a higher local recurrence than resection, ablation remains an important therapeutic option for many patients with hepatic metastasis.

KW - Colorectal metastases

KW - Hatic resection

KW - Liver

KW - Microwave ablation

KW - Nuroendocrine metastases

KW - Radiofrequency ablation

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=77951488571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951488571&partnerID=8YFLogxK

U2 - 10.1097/PPO.0b013e3181d7ea07

DO - 10.1097/PPO.0b013e3181d7ea07

M3 - Article

VL - 16

SP - 111

EP - 117

JO - Cancer journal (Sudbury, Mass.)

JF - Cancer journal (Sudbury, Mass.)

SN - 0765-7846

IS - 2

ER -